| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $21.75B | $22.49B | $22.10B | $20.42B | $20.61B |
| Cost of Revenue | – | $16.50B | $13.79B | $12.99B | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $625.00M | $686.00M | $617.00M | $539.00M | $503.00M |
| SG&A | $3.09B | $3.20B | $3.30B | $2.51B | $3.12B |
| Operating Income | $2.17B | $2.65B | $2.30B | $4.51B | $2.65B |
| Interest Expense | $458.00M | $580.00M | $362.00M | $302.00M | $319.00M |
| Tax Expense | $240.00M | $1.06B | $644.00M | $708.00M | $699.00M |
| Net Income | $1.48B | $5.60B | $1.44B | $3.58B | $1.70B |
| EPS (basic) | 1.7400 | 6.2400 | 1.6100 | 4.1900 | 1.9200 |
| EPS (diluted) | 1.7200 | 6.1500 | 1.5800 | 4.1000 | 1.8700 |
| Shares (diluted) | $862.40M | $911.70M | $853.00M | $861.20M | $890.30M |